Germany· DE-A57-11fc72e7d9bb1c83

Rapibloc

A landiolol product containing landiolol hydrochloride, registered in Germany by Amomed Pharma Gmbh. The same ATC class is registered in 15 of our 19 countries.

ATC C07AB14

Checked against EMA Article 57 (European Union) on September 30, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about landiolol hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Landiolol is registered in 15 of 19 countries.

Countries holding a registration under ATC C07AB14 (landiolol), each read from that country’s own register.

This record: Germany, from EMA Article 57 (European Union)
9 of them publish a price we can compare per daily dose

Search landiolol products by name

Landiolol · ATC C07AB14

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)

Active substance: Landiolol Hydrochloride
Manufacturer: Amomed Pharma Gmbh
Country: Germany (DE)
ATC code: C07AB14
ATC class: Landiolol
Reimbursed: Not published by this register
Source register: EMA Article 57 (European Union)
Last checked: September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Landiolol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All landiolol products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Rapibloc
Belgium · Runrapiq
Bulgaria · Рапиблок
Cyprus · Rapibloc
Czechia · Rapibloc
Denmark · Rapibloc
Estonia · Raploc
Spain · Rapibloc
Finland · Rapibloc
France · Rapibloc
Greece · Rapibloc
Croatia · Rapibloc
Hungary · Rapibloc
Ireland · Rapibloc
Italy · Landiobloc
Lithuania · Raploc
Latvia · Raploc
Netherlands · Landiolol Hydrochloride Orpha-Devel, Rapibloc
Norway · Raploc
Poland · Runrapiq
Portugal · Rapibloc
Romania · Rapibloc
Sweden · Rapibloc
Slovenia · Rapibloc
Slovakia · Rapibloc

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/5185b2b5-e661-4bac-a429-b8cd4b82b9bb
GET /v1/drugs/5185b2b5-e661-4bac-a429-b8cd4b82b9bb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Intravenous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Landiolol Hydrochloride",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

API reference MCP server Plans

See everything about landiolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console